Concert Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering

Published: Feb 19, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the closing of its initial public offering of 6,000,000 shares of its common stock at a public offering price of $14.00 per share, before underwriting discounts.

Help employers find you! Check out all the jobs and post your resume.

Back to news